ARS Pharmaceuticals Inc.
SPRY | NASDAQ
$4.35
+$0.24 (+5.84%)
At close: Sep 21, 2026, 4:00 PM ET
$4.46
+$0.11 (+2.53%)
Pre-market:
Sep 22, 2026, 8:28 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -62.34M | -60.62M | -41.32M | -51.15M | -44.88M | -33.94M | 49.93M | -19.13M | -12.52M | -10.29M | -7.17M | -14.87M | -17.37M | -14.96M | -14.43M | -6.58M | -6.42M | -7.25M | -23.46M | -22.66M | -24.5M | -18.87M |
Depreciation & Amortization | 416K | 397K | -1.54M | 2.35M | 279K | -1.68M | -1.52M | 21K | 18K | 11K | 12K | 21K | 20K | 20K | 14K | 7K | 488K | 50K | 430K | 541K | 492K | 466K |
Stock-Based Compensation | 12.4M | 7.42M | 5.74M | 5.69M | 5.37M | 5.3M | 4.26M | 3.59M | 3.37M | 3.32M | 2.28M | 2.61M | n/a | n/a | 4.76M | 460K | n/a | 264K | n/a | n/a | n/a | n/a |
Other Working Capital | -2.74M | -585K | 141K | 1.01M | 4.17M | -5.01M | -9.54M | -508K | 692K | 892K | -1.89M | -91K | 111K | -2.69M | -1.11M | 52K | -689K | 12K | -3.04M | -1.66M | 557K | -294K |
Other Non-Cash Items | 1.44M | -745K | 1.11M | -2.87M | 693K | n/a | n/a | 2.51M | -1.9M | -1.98M | 9.43M | -1.56M | 346K | 441K | -10.06M | 710K | -86K | -1K | 5.15M | 5.02M | 4.73M | 4.29M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -11.18M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -12.84M | 8.6M | -7.46M | -1.07M | -1.05M | -10.42M | -10.68M | -1.46M | 3.76M | 2.24M | -10.77M | 1.03M | 335K | 2.07M | -781K | -276K | -956K | 12K | -3.43M | -2.02M | 5.14M | 1.91M |
Operating Cash Flow | -60.93M | -44.95M | -43.49M | -47.05M | -39.59M | -40.74M | 42M | -14.47M | -7.28M | -6.71M | -17.41M | -12.76M | -16.67M | -12.43M | -20.5M | -5.68M | -6.97M | -6.93M | -21.31M | -19.12M | -14.14M | -12.2M |
Capital Expenditures | n/a | n/a | n/a | -197K | -51K | -91K | -302K | -140K | -38K | -83K | 91K | -43K | -30K | -193K | -126K | -30K | -22K | -21K | -550K | -87K | -700K | -35K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -25.95M | 46.6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -19.91M | -14.71M | -48.89M | -127.42M | -31.38M | -34.35M | -163.46M | -41.54M | -87.61M | -63.43M | -34.05M | -106.6M | n/a | -131.35M | n/a | n/a | n/a | n/a | -25.14M | -39.97M | n/a | n/a |
Sales Maturities Of Investments | 61.48M | 42.5M | 75M | 88.5M | 80M | 63.5M | 67M | 61M | 75M | 55M | 60M | 60M | 45M | 20M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | -2M | -5.86M | n/a | n/a | -5M | -2.5M | n/a | n/a | 25.95M | -46.6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 41.57M | 27.79M | 24.11M | -44.98M | 48.57M | 29.06M | -101.76M | 16.82M | -12.65M | -8.51M | 26.04M | -46.64M | 44.97M | -111.55M | -126K | -30K | -22K | -21K | -25.69M | -40.06M | -700K | -35K |
Debt Repayment | n/a | n/a | -732K | 96.99M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.95M | -909K | -910K | -908K | n/a | n/a | -496K | -350K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 2.41M | 97K | 83K | 2.58M | n/a | n/a | 69.38M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 199.77M | -647K | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 3.2M | 159K | 1.13M | 100.05M | 2.7M | 725K | 70.92M | 680K | 545K | 258K | 1.81M | 921K | 2.85M | 1.32M | 193.82M | -1.56M | -623K | -908K | 275K | 148K | 319K | -128K |
Net Cash Flow | -16.16M | -17M | -18.24M | 8.02M | 11.68M | -10.95M | 11.16M | 3.03M | -19.38M | -14.97M | 10.44M | -58.49M | 31.16M | -122.66M | 173.2M | -7.27M | -15.3M | -7.85M | -46.62M | -59.03M | -14.52M | -12.36M |
Free Cash Flow | -60.93M | -44.95M | -43.49M | -47.24M | -39.64M | -40.83M | 41.7M | -14.61M | -7.32M | -6.79M | -17.31M | -12.81M | -16.7M | -12.62M | -20.62M | -5.71M | -7M | -6.95M | -21.86M | -19.21M | -14.84M | -12.24M |
Adj. Free Cash Flow | -73.32M | -52.37M | -49.22M | -52.93M | -45.01M | -46.13M | 37.44M | -18.2M | -10.68M | -10.11M | -19.59M | -15.42M | -16.7M | -12.62M | -25.39M | -6.17M | -7M | -7.21M | -21.86M | -19.21M | -14.84M | -12.24M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -83K | 91K | -43K | -30K | -193K | -126K | -30K | -22K | -21K | -184.84K | -87K | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | -197K | -51K | -91K | -302K | -140K | -38K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -365.16K | n/a | -700K | -35K |
Owner Earnings | -60.93M | -44.95M | -43.49M | -47.05M | -39.59M | -40.74M | 42M | -14.47M | -7.28M | -6.79M | -17.31M | -12.81M | -16.7M | -12.62M | -20.62M | -5.71M | -7M | -6.95M | -21.49M | -19.21M | -14.14M | -12.2M |
Add to Watchlist
Select watchlists to add or remove SPRY